Clinical Trial Update: Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCT [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept study evaluating re-treatment with ranibizumab guided by OCT in branch retinal vein occlusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Branch Retinal Vein Occlusion

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: University of Leipzig | Conditions: Branch Retinal Vein Occlusion | Phase 2 | Status: COMPLETED